leuprorelin
ItalyDrugs containing this active substance
-
This medicine is used for the treatment of adult men with hormone-sensitive metastatic prostate cancer or high-risk hormone-sensitive non-metastatic prostate cancer in association with radiotherapy.
Form: suspension for injection, prolonged-release in pre-filled syringe
Active substance Dosage leuprorelin - ATC: L02AE02
Manufacturer: ACCORD HEALTHCARE, S.L.U.
-
The drug is used to treat prostate cancer in men; endometriosis, breast cancer in women nearing menopause, and uterine fibroids in women; and precocious puberty in children.
Form: solution for injection
Active substance Dosage leuprorelin - ATC: L02AE02
Manufacturer: TAKEDA ITALIA S.P.A.